MedPath

Clinical study on the efficacy and safety of Bushen Culuan fang in treating anovulatory infertility caused by hyperprolactinemia

Early Phase 1
Not yet recruiting
Conditions
Hyperprolactinemia
Registration Number
ITMCTR2024000017
Lead Sponsor
Xiyuan Hospital, Chinese Academy of Traditional Chinese medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria

(1) Between 20 and 40 years old;
(2) Meet the diagnostic criteria for infertility;
(3) Meet the diagnostic criteria of hyperprolactinemia;
(4) Meet the diagnostic criteria of TCM kidney deficiency and blood stasis syndrome;
(5) Voluntarily sign the informed consent.

Exclusion Criteria

(1) ovulation disorders or infertility caused by congenital physiological defects or malformations:
(2) infertility caused by genetic factors;
(3) Infertility caused by fallopian tube factors, or immune factors, or uterine fibroids, or myoadenosis, or endometriosis, or uterine dysplasia, confirmed by examination;
(4) abnormal reproductive function of the spouse;
(5) serious abnormalities of cardiovascular, liver, kidney or hematopoietic system;
(6) Psychiatric diseases and other diseases that cause abnormal lactation;
(7) Allergy to known investigational drug ingredients.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.